| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 538 | 5.272 | 7.098 | 6.562 | 9.834 |
| Total Income - EUR | - | - | - | - | - | 538 | 5.272 | 7.098 | 6.562 | 9.834 |
| Total Expenses - EUR | - | - | - | - | - | 110 | 2.132 | 3.044 | 2.248 | 2.860 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 427 | 3.141 | 4.054 | 4.314 | 6.973 |
| Net Profit/Loss - EUR | - | - | - | - | - | 411 | 2.983 | 3.841 | 3.563 | 5.820 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gynoprima Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 667 | 3.163 | 4.602 | 4.033 | 6.080 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 258 | 36 | 3.256 | 2.467 | 3.238 |
| Cash | - | - | - | - | - | 409 | 3.127 | 1.346 | 1.566 | 2.841 |
| Shareholders Funds | - | - | - | - | - | 452 | 3.031 | 4.246 | 3.611 | 5.868 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 215 | 132 | 357 | 422 | 211 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gynoprima Medical S.r.l.